Types of Cancer We Treat

Lung Cancer

Our expert lung cancer team works together to care for all types of cancer that affect the lungs and chest, including non-small cell lung cancer, small cell lung cancer, mesothelioma, and thymoma. We make every effort to ensure that your visits are as convenient as possible. You can often see multiple specialists on the same day, who collaborate to discuss your diagnosis and your entire care plan. You may be eligible to participate in clinical trials, which offer some of the newest therapies available.

Find a Doctor & Schedule
Lung Cancer Patient Stories
Non-Small Cell Lung Cancer
Small Cell Lung Cancer
Mesothelioma

Related News

Raising Awareness & Increasing Survival of Certain Cancers
Read Story
New Screening Strategy Casts a Wide Net for Lung Cancer
Read Story
Survivors Celebrate Immunotherapy for Lung Cancer Treatment
Read Story
Brooklynites Have Increased Access to Innovative Cancer Care
Read Story
Early Detection of Lung Cancer Improves Survival
Read Story
Medical Oncologist Discusses Lung Cancer Screening
Read Story
Lung Cancer Screening Program Expands at NYU Langone
Read Story
Diagnosing & Treating Lung Cancer Robotically, All at Once
Read Story
Medical Oncologist Reflects on Career Treating Lung Cancer
Read Story
Understanding Lung Cancer in Non-Smoking Asian Women
Read Story
New Drug Effective in Lung Cancers Caused by Genetic Error
Read Story
Using AI to Predict Immunotherapy Response in Lung Cancer
Read Story

Clinical Trials and Research Studies

Phase 5

PHASE 1/2A DOSE ESCALATION FINDING AND EXPANSION STUDY EVALUATING SAFETY TOLERABILITY PHARMACOKINETICS PHARMACODYNAMICS AND ANTI TUMOR ACTIVITY OF PF-07104091 AS A SINGLE AGENT AND IN COMBINATION THERAPY

Learn More

Phase 1

Phase 1 Open-Label Multicenter Dose Escalation Study of mRNA-2752 a Lipid Nanoparticle Encapsulating mRNAs Encoding Human OX40L IL-23 and IL-36? for Intratumoral Injection Alone and in Combination with Immune Checkpoint Blockade

Learn More

Phase 1

A Phase 1a/1b Study of LY3537982 in Patients with KRAS G12C-Mutant Advanced Solid Tumors

Learn More

Phase 5

A Phase 1/2a Multi-Center Open-Label Study to Evaluate the Safety Tolerability Pharmacokinetics and Preliminary Evidence of Antitumor Activity of JAB-3312 in combination with pembrolizumab or binimetinib in Adult Patients with Advanced Solid Tumors

Learn More
View All Related Clinical Trials (34)